Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program

被引：0
|
作者：
Winqvist, Maria
Andersson, Per-Ola
Asklid, Anna
Karlsson, Karin
Karlsson, Claes
Lauri, Birgitta
Lundin, Jeanette
Mattsson, Mattias
Norin, Stefan
Sandstedt, Anna Bergendahl
Hansson, Lotta
Osterborg, Anders
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5353
引用
收藏
页数：4
相关论文
共 50 条
  • [21] External Validation of a Novel Risk Model (BALL Score) in Real-World Relapsed/ Refractory Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib. a Campus CLL Study
    Gentile, Massimo
    Morabito, Fortunato
    Del Poeta, Giovanni
    Mauro, Francesca Romana
    Reda, Gianluigi
    Sportoletti, Paolo
    Laurenti, Luca
    Coscia, Marta
    Herishanu, Yair
    Recchia, Anna G.
    Varettoni, Marzia
    Murru, Roberta
    Chiarenza, Annalisa
    Condoluci, Adalgisa
    Moia, Riccardo
    Pietrasanta, Daniela
    Loseto, Giacomo
    Consoli, Ugo
    Scortechini, Ilaria
    Rossi, Francesca Maria
    Zucchetto, Antonella
    Vigna, Ernesto
    Tripepi, Giovanni
    Rago, Angela
    Angeletti, Ilaria
    Biagi, Annalisa
    Del Giudice, Ilaria
    Bomben, Riccardo
    Rigolin, Gian Matteo
    Rossi, Davide
    Di Raimondo, Francesco
    Gaidano, Gianluca
    Polliack, Aaron
    Cuneo, Antonio
    Foa, Robin
    Gattei, Valter
    BLOOD, 2019, 134
  • [22] Drug-eluting stent restenosis in real-world clinical practice: 6-month angiographic follow-up results
    Rha, SW
    Cheon, BW
    Moon, SK
    Kim, HH
    Kim, JW
    Hong, SJ
    Park, CG
    Seo, HS
    Oh, DJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (8A): : 47A - 47A
  • [23] REAL-WORLD CHARACTERISTICS, TREATMENT PATHWAYS AND HEALTHCARE RESOURCE USE IN PATIENTS TREATED FOR RELAPSED REFRACTORY MULTIPLE MYELOMA IN SPAIN: PRELIMINARY RESULTS FROM THE PREMIERE STUDY
    Martinez-Lopez, J.
    Martin-Regueira, P.
    Zagorska, A.
    Lefevre, C.
    Roldan Acevedo, C.
    Qizilbash, N.
    San Jose, B.
    Mendez, I.
    Casado Montero, L. F.
    HAEMATOLOGICA, 2016, 101 : 835 - 835
  • [24] Updated Follow-up of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated with Lisocabtagene Maraleucel in the Phase 1 Monotherapy Cohort of Transcend CLL 004, Including High-Risk and Ibrutinib-Treated Patients
    Siddiqi, Tanya
    Soumerai, Jacob D.
    Dorritie, Kathleen A.
    Stephens, Deborah M.
    Riedell, Peter A.
    Arnason, Jon E.
    Kipps, Thomas J.
    Gillenwater, Heidi H.
    Gong, Lucy
    Yang, Lin
    Ogasawara, Ken
    Wierda, William G.
    BLOOD, 2020, 136
  • [25] Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry
    Tamburino, Corrado
    Barbagallo, Rossella
    Capodanno, Davide
    di Matteo, Sergio
    Colombo, Giorgio L.
    Recchia, Martino
    Ciriminna, Saverio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2009, 10 (04) : 322 - 329
  • [26] Polatuzumab Vedotin in Relapsed and Refractory (r/r) Large B-Cell Lymphoma (LBCL): Real-World Data of the German National Compassionate Use Program (CUP)
    Liebers, Nora
    Duell, Johannes
    Norenberg, Daniel
    Kaebisch, Eva
    Kerkhoff, Andrea
    Acker, Fabian
    Fuhrmann, Stephan
    Leng, Corinna
    Welslau, Manfred
    Chemnitz, Jens
    Middeke, Jan Moritz
    Weber, Thomas
    Trappe, Ralf Ulrich
    Pfannes, Roald
    Liersch, Ruediger
    Spoer, Christian
    Gebauer, Niklas
    Fuxius, Stefan
    Caille, Leandra
    Pott, Christiane
    Koenecke, Christian
    Holtick, Udo
    Geer, Thomas
    Keller, Ulrich
    Claus, Rainer
    Mougiakakos, Dimitrios
    Mayer, Stephanie
    Huttmann, Andreas
    Trummer, Arne
    Wulf, Gerald
    Brunnberg, Uta
    Bullinger, Lars
    Hess, Georg
    Mueller-Tidow, Carsten
    Glass, Bertram
    Lenz, Georg
    Dreger, Peter
    Dietrich, Sascha
    BLOOD, 2020, 136
  • [27] The Transfer of Cognitive Training to Real-World Functioning: Results of our First Six Pilot Subjects at Six-Month Follow-Up
    Blake, Jason A.
    Mitchell, Brandon
    McKay, Staci
    Uswatte, Gitendra
    Taub, Edward
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2021, 36 (06) : 1187 - 1188
  • [28] The longest available clinical follow-up of a cohort of real-world patients treated exclusively with drug-eluting stents
    Costa, J. R., Jr.
    Sousa, A. G. M. R. S.
    Moreira, A. C. M.
    Costa, R. A. C., Jr.
    Cano, M. N. C.
    Maldonado, G. A. M.
    Sousa, J. E. S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 511 - 511
  • [29] Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Additional patients and extended follow-up from BRUIN
    Munir, Talha
    Mato, Anthony R.
    Woyach, Jennifer A.
    Brown, Jennifer R.
    Ghia, Paolo
    Patel, Krish
    Eyre, Toby A.
    Lech-Maranda, Ewa
    Lamanna, Nicole
    Tam, Constantine S.
    Seymour, John F.
    Shah, Nirav N.
    Coombs, Catherine C.
    Ujjani, Chaitra S.
    Patel, Manish R.
    Fakhri, Bita
    Cheah, Chan Y.
    Alencar, Alvaro J.
    Cohen, Jonathon B.
    Gerson, James N.
    Flinn, Ian W.
    Ma, Shuo
    Jagadeesh, Deepa
    Rhodes, Joanna M.
    Hernandez-Ilizaliturri, Francisco
    Zinzani, Pier Luigi
    Balbas, Minna
    Nair, Binoj
    Abada, Paolo
    Wang, Chunxiao
    Wang, Denise
    Tsai, Donald E.
    Wierda, William G.
    Jurczak, Wojciech
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 110 - 111
  • [30] AUTOMATED BOLUS ADVISOR USE BESTOWS GLYCEMIC BENEFITS TO MDI-TREATED PEOPLE WITH DIABETES IN REAL-WORLD SETTINGS: FOLLOW-UP RESULTS FROM ABACUS
    Schweitzer, M. A.
    Cavan, D. A.
    Ziegler, R.
    Cranston, I.
    Barnard, K.
    Ryder, J.
    Parkin, C. G.
    Vesper, I.
    Petersen, B.
    Wagner, R. S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A87 - A87
12345